146 related articles for article (PubMed ID: 37866219)
1. Risk evaluation of diabetic ketoacidosis associated with antipsychotics among patients with schizophrenia in the Japanese adverse event report database.
Sugawara N; Yasui-Furukori N; Shimoda K
J Psychosom Res; 2023 Dec; 175():111533. PubMed ID: 37866219
[TBL] [Abstract][Full Text] [Related]
2. Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Polcwiartek C; Vang T; Bruhn CH; Hashemi N; Rosenzweig M; Nielsen J
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3663-3672. PubMed ID: 27592232
[TBL] [Abstract][Full Text] [Related]
3. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.
Vuk A; Kuzman MR; Baretic M; Osvatic MM
Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569
[TBL] [Abstract][Full Text] [Related]
4. Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case-control study.
Polcwiartek C; Kragholm K; Rohde C; Hashemi N; Vang T; Nielsen J
Diabetologia; 2017 Sep; 60(9):1678-1690. PubMed ID: 28593353
[TBL] [Abstract][Full Text] [Related]
5. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
Henderson DC; Cagliero E; Copeland PM; Louie PM; Borba CP; Fan X; Freudenreich O; Goff DC
J Clin Psychiatry; 2007 Apr; 68(4):533-41. PubMed ID: 17474808
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Diabetic Ketoacidosis Associated With Antipsychotic Medication: Literature Review.
Vuk A; Baretic M; Osvatic MM; Filipcic I; Jovanovic N; Kuzman MR
J Clin Psychopharmacol; 2017 Oct; 37(5):584-589. PubMed ID: 28816925
[TBL] [Abstract][Full Text] [Related]
7. Fatal diabetic ketoacidosis and antipsychotic medication.
Ely SF; Neitzel AR; Gill JR
J Forensic Sci; 2013 Mar; 58(2):398-403. PubMed ID: 23278567
[TBL] [Abstract][Full Text] [Related]
8. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.
He Z; Lam K; Zhao W; Yang S; Li Y; Mo J; Gao S; Liang D; Qiu K; Huang M; Wu J
Acta Diabetol; 2023 Mar; 60(3):401-411. PubMed ID: 36576563
[TBL] [Abstract][Full Text] [Related]
9. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases.
Jin H; Meyer JM; Jeste DV
Ann Clin Psychiatry; 2002 Mar; 14(1):59-64. PubMed ID: 12046641
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine-induced diabetic ketoacidosis.
Ragucci KR; Wells BJ
Ann Pharmacother; 2001 Dec; 35(12):1556-8. PubMed ID: 11793618
[TBL] [Abstract][Full Text] [Related]
11. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
Ramaswamy K; Kozma CM; Nasrallah H
Drug Saf; 2007; 30(7):589-99. PubMed ID: 17604410
[TBL] [Abstract][Full Text] [Related]
12. Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study.
Bobo WV; Cooper WO; Epstein RA; Arbogast PG; Mounsey J; Ray WA
BMC Med Res Methodol; 2011 Nov; 11():157. PubMed ID: 22112194
[TBL] [Abstract][Full Text] [Related]
13. Factors in antipsychotic drug selection: tolerability considerations.
Nasrallah HA
CNS Spectr; 2003 Nov; 8(11 Suppl 2):23-5. PubMed ID: 14978455
[TBL] [Abstract][Full Text] [Related]
14. New onset diabetes with ketoacidosis attributed to quetiapine.
Marlowe KF; Howard D; Chung A
South Med J; 2007 Aug; 100(8):829-31. PubMed ID: 17713311
[TBL] [Abstract][Full Text] [Related]
15. Diabetic ketoacidosis associated with aripiprazole.
Church CO; Stevens DL; Fugate SE
Diabet Med; 2005 Oct; 22(10):1440-3. PubMed ID: 16176209
[TBL] [Abstract][Full Text] [Related]
16. New-onset diabetes and ketoacidosis with atypical antipsychotics.
Wilson DR; D'Souza L; Sarkar N; Newton M; Hammond C
Schizophr Res; 2003 Jan; 59(1):1-6. PubMed ID: 12413635
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature.
Muench J; Carey M
J Am Board Fam Pract; 2001; 14(4):278-82. PubMed ID: 11458971
[TBL] [Abstract][Full Text] [Related]
18. The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system.
Yang Z; Yu M; Mei M; Chen C; Lv Y; Xiang L; Li R
Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):504-510. PubMed ID: 34895802
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycemia and antipsychotic medications.
Haupt DW; Newcomer JW
J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
[TBL] [Abstract][Full Text] [Related]
20. Alpelisib-Induced Diabetic Ketoacidosis: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System and Review of the Literature.
Ziegengeist JL; Elmes JB; Strassels SA; Patel JN; Moore DC
Clin Breast Cancer; 2024 Jun; 24(4):e204-e209. PubMed ID: 38245400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
